# FDA Inspection 843341 - OneBlood, Inc. - August 05, 2013

Source: https://www.keypedia.com/records/fda_inspections/oneblood-inc/019f222f-c7f3-4e32-8443-7aa90d59d2f7
Source feed: FDA_Inspections

> FDA Inspection 843341 for OneBlood, Inc. on August 05, 2013. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 843341
- Company Name: OneBlood, Inc.
- Inspection Date: 2013-08-05
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 987023 - 2016-08-18](https://www.keypedia.com/records/fda_inspections/oneblood-inc/1d84d411-4439-48c3-b97d-8a1d1453af9e)
- [FDA Inspection 856468 - 2013-11-13](https://www.keypedia.com/records/fda_inspections/oneblood-inc/0cad2e83-46dd-47c7-aaf2-c30ab3a9f55f)
- [FDA Inspection 744447 - 2011-09-12](https://www.keypedia.com/records/fda_inspections/oneblood-inc/7f6b00ab-0046-4f91-b1b3-4343a1a89628)
- [FDA Inspection 571983 - 2009-03-03](https://www.keypedia.com/records/fda_inspections/oneblood-inc/7efdfc3e-4d08-4332-96da-f220f773ee70)

Company: https://www.keypedia.com/companies/oneblood-inc/bda6eba7-29c3-479c-a5a7-379d6787b3ce

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d